Cargando…
Hypersensitivity Cross-Reactivity for Ultrasound-Enhancing Agents and COVID-19 Vaccines
Autores principales: | Desai, Anish K., Hodovan, James, Belcik, J. Todd, Lindner, Jonathan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby-Year Book
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847109/ https://www.ncbi.nlm.nih.gov/pubmed/35182748 http://dx.doi.org/10.1016/j.echo.2022.02.006 |
Ejemplares similares
-
Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy
por: Roldan, Paola, et al.
Publicado: (2022) -
Resting coronary flow drives the daily pattern in coronary flow reserve in patients with chest pain without obstructive epicardial stenosis
por: Thosar, Saurabh S., et al.
Publicado: (2023) -
Oral antiplatelet agent hypersensitivity and cross-reactivity managed by successful desensitisation
por: Chin, Nicholas, et al.
Publicado: (2015) -
Immunologic Evaluation of Ofloxacin Hypersensitivity
por: Nam, Young-Hee, et al.
Publicado: (2012) -
Skin Test Results and Cross-Reactivity Patterns in IgE- and T-Cell-Mediated Allergy to Gadolinium-Based Contrast Agents
por: Grueber, Hans-Peter, et al.
Publicado: (2021)